# Donepezil Treatment of Psychotic Symptoms in Dementia Patients

> **NCT00190021** · PHASE3 · UNKNOWN · sponsor: **Beersheva Mental Health Center** · enrollment: 80 (estimated)

## Conditions studied

- Dementia of Alzheimer Type

## Interventions

- **DRUG:** donepezil

## Key facts

- **NCT ID:** NCT00190021
- **Lead sponsor:** Beersheva Mental Health Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2010-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00190021

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00190021, "Donepezil Treatment of Psychotic Symptoms in Dementia Patients". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00190021. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*